The -13.88% Decline of Alkermes plc’s (ALKS) Stock in the Past Quarter

In the past week, ALKS stock has gone down by -1.18%, with a monthly decline of -9.66% and a quarterly surge of 4.83%. The volatility ratio for the week is 2.19%, and the volatility levels for the last 30 days are 2.46% for Alkermes plc The simple moving average for the past 20 days is -4.15% for ALKS’s stock, with a 6.38% simple moving average for the past 200 days.

Is It Worth Investing in Alkermes plc (NASDAQ: ALKS) Right Now?

The price-to-earnings ratio for Alkermes plc (NASDAQ: ALKS) is 14.48x, which is above its average ratio. Moreover, the 36-month beta value for ALKS is 0.49. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 2 as “overweight,” 5 as “hold,” and 1 as “sell.”

The public float for ALKS is 158.79M and currently, short sellers hold a 7.87% of that float. On January 10, 2025, ALKS’s average trading volume was 1.67M shares.

ALKS) stock’s latest price update

Alkermes plc (NASDAQ: ALKS)’s stock price has decreased by -0.42 compared to its previous closing price of 28.54. However, the company has seen a -1.18% decrease in its stock price over the last five trading sessions. prnewswire.com reported 2025-01-02 that DUBLIN, Jan. 2, 2025 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 43rd Annual J.P. Morgan Healthcare Conference.

Analysts’ Opinion of ALKS

Many brokerage firms have already submitted their reports for ALKS stocks, with Stifel repeating the rating for ALKS by listing it as a “Buy.” The predicted price for ALKS in the upcoming period, according to Stifel is $36 based on the research report published on November 05, 2024 of the previous year 2024.

TD Cowen, on the other hand, stated in their research note that they expect to see ALKS reach a price target of $34. The rating they have provided for ALKS stocks is “Buy” according to the report published on June 17th, 2024.

Robert W. Baird gave a rating of “Outperform” to ALKS, setting the target price at $37 in the report published on March 19th of the previous year.

ALKS Trading at -2.12% from the 50-Day Moving Average

After a stumble in the market that brought ALKS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.56% of loss for the given period.

Volatility was left at 2.46%, however, over the last 30 days, the volatility rate increased by 2.19%, as shares sank -9.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.93% upper at present.

During the last 5 trading sessions, ALKS fell by -1.18%, which changed the moving average for the period of 200-days by +4.14% in comparison to the 20-day moving average, which settled at $29.65. In addition, Alkermes plc saw -1.18% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALKS starting from Hopkinson Craig C., who sale 61,151 shares at the price of $32.07 back on Dec 09 ’24. After this action, Hopkinson Craig C. now owns 47,576 shares of Alkermes plc, valued at $1,961,406 using the latest closing price.

LAURENCIN CATO T, the Director of Alkermes plc, sale 2,691 shares at $31.85 during a trade that took place back on Dec 09 ’24, which means that LAURENCIN CATO T is holding 23,013 shares at $85,708 based on the most recent closing price.

Stock Fundamentals for ALKS

Current profitability levels for the company are sitting at:

  • 0.21 for the present operating margin
  • 0.82 for the gross margin

The net margin for Alkermes plc stands at 0.22. The total capital return value is set at 0.18. Equity return is now at value 29.23, with 17.45 for asset returns.

Based on Alkermes plc (ALKS), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at 1.23. The debt to equity ratio resting at 0.22. The interest coverage ratio of the stock is 13.03.

Currently, EBITDA for the company is 519.48 million with net debt to EBITDA at -0.08. When we switch over and look at the enterprise to sales, we see a ratio of 3.04. The receivables turnover for the company is 4.07for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.45.

Conclusion

To wrap up, the performance of Alkermes plc (ALKS) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts